GNH USA

Europe — EMA

Kybernin P

GNH USA supplies Kybernin P (Antithrombin III), a anticoagulant for prevention and treatment of thromboembolic disorders. Request a quote for global supply.

Antithrombin Iii

Request sourcing

1
Pack/s

What is Antithrombin Iii?

Antithrombin III, the active ingredient in Kybernin P, is a anticoagulant presented as an injectable solution for intravenous use. It is used for the prevention and treatment of thromboembolic disorders in patients at risk of clot formation.

GNH USA supplies Kybernin P as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Antithrombin Iii used for?

Kybernin P, an antithrombin III concentrate, is used in the antithrombotic pathway to manage thromboembolic conditions.

- Deep vein thrombosis: prevents clot propagation and facilitates resolution. - Pulmonary embolism: aids in treatment and reduces recurrence risk. - Anticoagulation during surgery: provides anticoagulant support for patients with antithrombin deficiency.

What are the side effects of Antithrombin Iii?

Common Side Effects: - Infusion‑related reactions such as flushing or chills. - Mild fever or chills. - Headache. - Nausea. - Transient hypotension. - Local site erythema.

Serious or Rare Side Effects: - Anaphylactic or severe allergic reactions. - Unexpected bleeding or hemorrhage. - Thrombosis despite therapy. - Hemolysis. - Renal dysfunction. - Severe hypotension requiring intervention.

What precautions apply to Antithrombin Iii?

Kybernin P requires careful clinical monitoring and adherence to handling guidelines.

- Monitor antithrombin activity levels: ensure therapeutic range is achieved. - Assess bleeding risk before and during therapy. - Evaluate for heparin resistance: consider dose adjustments. - Use caution in patients with liver disease or coagulopathy. - Avoid administration to individuals with known hypersensitivity to antithrombin products. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Antithrombin Iii interact with?

Kybernin P may interact with other anticoagulant and antiplatelet agents.

Major Interactions (Avoid): - Concomitant high‑dose heparin: risk of excessive anticoagulation. - Warfarin: may potentiate anticoagulant effect, requiring INR monitoring. - Direct oral anticoagulants (DOACs): increased bleeding risk.

Moderate Interactions (Monitor Closely): - Antiplatelet drugs (e.g., aspirin, clopidogrel): monitor for bleeding. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may enhance hemorrhagic tendency. - ACE inhibitors or ARBs: watch for hypotension when combined with rapid infusion.

Frequently asked questions

What is Kybernin P used for?+
Kybernin P is an intravenous antithrombin III concentrate used to prevent and treat thromboembolic disorders such as deep‑vein thrombosis, pulmonary embolism, and to provide anticoagulant support during surgery for patients with antithrombin deficiency.
How does Antithrombin III work in Kybernin P?+
Antithrombin III in Kybernin P binds to and inactivates key clotting enzymes, primarily thrombin (factor IIa) and factor Xa. By enhancing the natural inhibition of these enzymes, it reduces the formation of fibrin clots and helps restore normal blood coagulation balance.
What is the usual dose of Kybernin P?+
The dosage of Kybernin P is determined by the prescribing clinician based on the patient’s antithrombin activity, weight, clinical condition, and therapeutic goals. Only a qualified healthcare professional should set the appropriate dosing regimen.
Is Kybernin P safe to use during pregnancy or breastfeeding?+
Safety data for Antithrombin III in pregnancy or lactation are limited. The decision to use Kybernin P in these populations should be made by a qualified physician after weighing potential benefits against possible risks to the mother and child.
How do I order Kybernin P from GNH USA?+
To order Kybernin P, submit an enquiry on the product page at gnh-usa.com with the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required) and necessary import documentation.
How does Kybernin P compare with other antithrombotic therapies?+
Kybernin P provides direct replacement of antithrombin activity, which is especially useful in patients with antithrombin deficiency or heparin resistance. Unlike heparin or direct oral anticoagulants, it does not rely on endogenous antithrombin levels and offers a targeted mechanism, but it requires intravenous administration and careful monitoring.
What are the storage and handling requirements for Kybernin P?+
Kybernin P must be stored refrigerated at 2‑8 °C, protected from light, and must never be frozen or shaken. Prior to use, allow the product to reach room temperature if required, and follow aseptic techniques for intravenous preparation.
How is Kybernin P administered?+
Kybernin P is administered by intravenous infusion under the supervision of a qualified healthcare professional. The infusion rate and total dose are individualized based on the patient’s clinical status and laboratory monitoring of antithrombin activity.
What are the most serious risks associated with Kybernin P?+
Serious risks include severe allergic reactions such as anaphylaxis, unexpected bleeding or hemorrhage, and paradoxical thrombosis despite therapy. Patients should be monitored closely for signs of these events, and immediate medical attention is required if they occur.
Who should not use Kybernin P?+
Kybernin P should not be used in individuals with known hypersensitivity to antithrombin III products or any of the formulation components. Caution is also advised for patients with active, uncontrolled bleeding, severe liver disease, or those receiving incompatible anticoagulant regimens without proper monitoring.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Antithrombin Iii
Route
Intravenous Use
Manufacturer
Csl Behring Gmbh
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU